XML 41 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Sonder Legacy Warrants
Delayed Draw Warrants
As Previously Reported
Additional Paid-in Capital
Additional Paid-in Capital
Sonder Legacy Warrants
Additional Paid-in Capital
Delayed Draw Warrants
Additional Paid-in Capital
As Previously Reported
Accumulated Translation Adjustment
Accumulated Translation Adjustment
As Previously Reported
Accumulated Deficit
Accumulated Deficit
As Previously Reported
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
As Previously Reported
Redeemable Convertible Preferred Stock
Revision of Prior Period, Adjustment
Exchangeable Preferred Stock
Exchangeable Preferred Stock
As Previously Reported
Exchangeable Preferred Stock
Revision of Prior Period, Adjustment
Common Stock
Common Stock
Common Stock
Common Stock
Sonder Legacy Warrants
Common Stock
Common Stock
As Previously Reported
Common Stock
Common Stock
Revision of Prior Period, Adjustment
Exchangeable Series AA Stock
Common Stock
Exchangeable Series AA Stock
Common Stock
As Previously Reported
Exchangeable Series AA Stock
Common Stock
Revision of Prior Period, Adjustment
Post-Combination Exchangeable Common Stock
Post-Combination Exchangeable Common Stock
Common Stock
Post-Combination Exchangeable Common Stock
Common Stock
As Previously Reported
Post-Combination Exchangeable Common Stock
Common Stock
Revision of Prior Period, Adjustment
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021                         111,271,424 75,767,082 35,504,342 18,499,408 12,570,228 5,929,180                      
Mezzanine equity, beginning balance at Dec. 31, 2021                         $ 518,750 $ 518,750   $ 49,733 $ 49,733                        
Increase (Decrease) in Mezzanine Equity                                                          
Conversion of preferred stock (in shares)                         (111,271,424)     (18,499,408)                          
Conversion of preferred stock                         $ (518,750)     $ (49,733)                          
Mezzanine equity, ending balance (in shares) at Mar. 31, 2022                         0     0                          
Mezzanine equity, ending balance at Mar. 31, 2022                         $ 0     $ 0                          
Beginning balance (in shares) at Dec. 31, 2021                                     12,752,202   8,684,246 4,067,956 13,835,946 9,421,190 4,414,756   0 0 0
Beginning balance at Dec. 31, 2021 $ (764,406)     $ (764,406) $ 43,106     $ 43,106 $ 7,299 $ 7,299 $ (814,812) $ (814,812)             $ 1   $ 1   $ 0 $ 0     $ 0 $ 0  
Increase (Decrease) in Stockholders' Equity (Deficit)                                                          
Exercise of common stock options (in shares)                                     362,943                    
Exercise of common stock options 873       873                                                
Conversion of Legacy Sonder Warrants from liabilities to equity 2,111       2,111                                                
CEO promissory note settlement (in shares)                                     (2,725,631)                    
Conversion of Sonder Legacy Warrants (in shares)                                       155,239                  
Conversion of Legacy Sonder Warrants   $ 1,243       $ 1,243                                              
Conversion of convertible note (in shares)                                     19,017,105                    
Conversion of convertible note 159,173       159,172                           $ 1                    
Conversion of preferred stock (in shares)                                     111,271,424                    
Conversion of preferred stock 518,761       518,750                           $ 11                    
Conversion of exchangeable stock (in shares)                                             (13,835,946)       32,335,354    
Conversion of exchangeable stock 49,733       49,733                                                
Issuance of common stock in connection with Business Combination and PIPE offering (in shares)                                     43,845,835                    
Issuance of common stock in connection with business combination and PIPE offering 267,362       267,355                           $ 7                    
Assumption of SPAC Warrants upon consummation of business combination (25,985)     (38,135) (25,985)                                                
Earn Out Liability recognized upon consummation of business combination (98,117)       (98,117)                                                
Issuance of Delayed Draw Warrants     $ 5,598       $ 5,598                                            
Stock-based compensation 6,680       6,680                                                
Net (loss) income 10,963     22,392             10,963                                    
Change in cumulative translation adjustment 1,999               1,999                                        
Ending balance (in shares) at Mar. 31, 2022                                     184,679,117       0       32,335,354    
Ending balance at Mar. 31, 2022 135,988     $ 135,267 930,519       9,298   (803,849)               $ 20       $ 0       $ 0    
Beginning balance (in shares) at Dec. 31, 2022                                     198,394,331             20,389,216 20,389,216    
Beginning balance at Dec. 31, 2022 (19,947)       947,601       12,985   (980,554)               $ 21               $ 0    
Increase (Decrease) in Stockholders' Equity (Deficit)                                                          
Exercise of common stock options (in shares)                                     9,266                    
Exercise of common stock options 8       8                                                
Vesting of restricted stock units (in shares)                                     517,068                    
Vesting of restricted stock units 0                                                        
Conversion of exchangeable stock (in shares)                                     930,512               (930,512)    
Conversion of exchangeable stock 0                                                        
Stock-based compensation 12,180       12,180                                                
Net (loss) income (86,431)                   (86,431)                                    
Change in cumulative translation adjustment (2,637)               (2,637)                                        
Ending balance (in shares) at Mar. 31, 2023                                     199,851,177             19,458,704 19,458,704    
Ending balance at Mar. 31, 2023 $ (96,827)       $ 959,789       $ 10,348   $ (1,066,985)               $ 21               $ 0